Macfarlanes has advised Hayfin in relation to a facility with Essex Bidco, an English company backed by Essex Woodlands Fund IX L.P., in order to finance the acquisition of a number of pharmaceutical products and medical devices from Jazz Pharmaceuticals.

As part of the acquisition, Essex Bidco Ltd also acquired the EUSA Pharma brand and will trade under this name.

The Macfarlanes team was led by banking and finance partner Andrew Perkins.  Partner Malcolm Walton advised on the pharmaceutical aspects of the deal.